Ocular Cystinosis: A Keynote for Diagnosis of Nephropathic Cystinosis in Egyptian Children

Akmal Rizk

Research Institute of Ophthalmology1, Magrabi Eye Hospital, Cairo, Egypt

Purpose: Nephropathic cystinosis is rare genetic disease characterized by defective lysosomal cystine transport and increased lysosomal cystine. The eye is one of the first organ affected.

Methods: Corneal Cystine Crystal Scoring (CCCS) (0.0-3.0) for diagnosis of nephropathic cystinosis was studied in all suspected children with renal Fanconi syn¬drome and siblings of diagnosed cases over a two year period. In addition to oral cysteamine, cys-teamine eye drops 0.55% were provided to all diagnosed patients and CCCS was followed up on a quarterly basis.

Results: Of 33 screened cases, 14 had corneal cystine crystals. Crystals were absent in two cystinotic patients under the age of 20 months. Both conjunctival and iris crystals were found in two patients. Retinal deposits were diagnosed in three patients. The mean age at diagnosis was 52.7 months and five patients had ERSD. After six months of treatment, the mean CCCS did not increase from the initial value of 1.81; associated with a decrease of 0.5 in two cases and a similar increase in two others. Scores decreased in two other patients after 12 months. Compliance was generally inadequate due to the high frequency of administration and the need for multi-drug regimen.

Conclusions:CCCS is a simple and reasonably sensitive method for diagnosis of nephropathic cystinosis above two years of age. To¬pical treatment with cysteamine eye drops prevents progression of deposits and may decrease it with adequate compliance. Further follow up is still recommended to monitor long term effects of both systemic and topical cysteamine therapy.